Clinical Trial Update: Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update addressing cardiotoxicity prevention in breast cancer patients treated with anthracyclines and/or trastuzumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cardiotoxicity

Snippet

Sponsor: Azienda Ospedaliero-Universitaria Careggi | Conditions: Breast Cancer, Cardiotoxicity | Phase 3 | Status: UNKNOWN